Overview
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner.
Dr. Worden is highly rated in 33 conditions, according to our data. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).
His clinical research consists of co-authoring 188 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception A, Ann Arbor, MI 48109
Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Worden has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
21 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma.
Rogel Cancer Center
Scott Schuetze is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 36 conditions, according to our data. Her top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy.
Frequently Asked Questions about Dr. Francis P. Worden
How do I make an appointment with Dr. Francis P. Worden?
You can book an appointment with Dr. Francis P. Worden by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Francis P. Worden a top-rated expert for Laryngeal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Francis P. Worden is classified as an Elite expert for Laryngeal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Francis P. Worden specialize in?
While Dr. Francis P. Worden is a Oncology, they have specific expertise in Laryngeal Cancer, Throat Cancer, and Thyroid Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Francis P. Worden participate in research or clinical trials?
Yes. Dr. Francis P. Worden has published 188 articles and abstracts on conditions like Laryngeal Cancer. You can view a list of Dr. Francis P. Worden's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Francis P. Worden accept my insurance?
Dr. Francis P. Worden accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adenoid Cystic CarcinomaDr. Worden isElite. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Worden isElite. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Worden isElite. Learn about Adrenocortical Carcinoma.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Laryngeal CancerDr. Worden isElite. Learn about Laryngeal Cancer.
- Throat CancerDr. Worden isElite. Learn about Throat Cancer.
- Distinguished
- Anaplastic Thyroid CancerDr. Worden isDistinguished. Learn about Anaplastic Thyroid Cancer.
- Follicular Thyroid CancerDr. Worden isDistinguished. Learn about Follicular Thyroid Cancer.
- Hereditary NeuroblastomaDr. Worden isDistinguished. Learn about Hereditary Neuroblastoma.
- Medullary Thyroid CarcinomaDr. Worden isDistinguished. Learn about Medullary Thyroid Carcinoma.
- Nasopharyngeal CarcinomaDr. Worden isDistinguished. Learn about Nasopharyngeal Carcinoma.
- NeuroblastomaDr. Worden isDistinguished. Learn about Neuroblastoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Basal Cell Skin CancerDr. Worden isAdvanced. Learn about Basal Cell Skin Cancer.
- Bone TumorDr. Worden isAdvanced. Learn about Bone Tumor.
- Eccrine PorocarcinomaDr. Worden isAdvanced. Learn about Eccrine Porocarcinoma.
- Epithelial-Myoepithelial Carcinoma
- Ewing SarcomaDr. Worden isAdvanced. Learn about Ewing Sarcoma.
- Experienced
- Adrenal Insufficiency PediatricDr. Worden isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Adult Soft Tissue SarcomaDr. Worden isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Worden isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Worden isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Worden isExperienced. Learn about Anal Cancer.
- AnemiaDr. Worden isExperienced. Learn about Anemia.